{"id":"https://openalex.org/W1495535606","doi":"https://doi.org/10.1002/jbmr.2351","title":"A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density","display_name":"A Randomized, Double-Blind Phase 2 Clinical Trial of Blosozumab, a Sclerostin Antibody, in Postmenopausal Women with Low Bone Mineral Density","publication_year":2014,"publication_date":"2014-09-05","ids":{"openalex":"https://openalex.org/W1495535606","doi":"https://doi.org/10.1002/jbmr.2351","mag":"1495535606","pmid":"https://pubmed.ncbi.nlm.nih.gov/25196993"},"language":"en","primary_location":{"id":"doi:10.1002/jbmr.2351","doi":"https://doi.org/10.1002/jbmr.2351","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jbmr.2351","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.2351","source":{"id":"https://openalex.org/S128199769","display_name":"Journal of Bone and Mineral Research","issn_l":"0884-0431","issn":["0884-0431","1523-4681"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bone and Mineral Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.2351","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052478195","display_name":"Robert R. Recker","orcid":"https://orcid.org/0000-0002-8774-1404","observed_orcids":["https://orcid.org/0000-0002-8774-1404"]},"institutions":[{"id":"https://openalex.org/I114493937","display_name":"Creighton University","ror":"https://ror.org/05wf30g94","country_code":"US","type":"education","lineage":["https://openalex.org/I114493937"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robert R. Recker","raw_affiliation_strings":["Osteoporosis Research CenterCreighton UniversityOmahaNEUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Osteoporosis Research CenterCreighton UniversityOmahaNEUSA","institution_ids":["https://openalex.org/I114493937"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023603655","display_name":"Charles Benson","orcid":"https://orcid.org/0000-0002-7681-5746","observed_orcids":["https://orcid.org/0000-0002-7681-5746"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charles T. Benson","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004644505","display_name":"Toshio Matsumoto","orcid":"https://orcid.org/0000-0002-0618-0941","observed_orcids":["https://orcid.org/0000-0002-0618-0941"]},"institutions":[{"id":"https://openalex.org/I922474255","display_name":"Tokushima University","ror":"https://ror.org/044vy1d05","country_code":"JP","type":"education","lineage":["https://openalex.org/I922474255"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Toshio Matsumoto","raw_affiliation_strings":["Fuji Memorial Institute of Medical SciencesUniversity of TokushimaTokushimaJapan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fuji Memorial Institute of Medical SciencesUniversity of TokushimaTokushimaJapan","institution_ids":["https://openalex.org/I922474255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045290077","display_name":"Michael A. Bolognese","orcid":"https://orcid.org/0000-0002-7102-5518","observed_orcids":["https://orcid.org/0000-0002-7102-5518"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Bolognese","raw_affiliation_strings":["Bethesda Health ResearchBethesdaMDUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bethesda Health ResearchBethesdaMDUSA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081732583","display_name":"Deborah A. Robins","orcid":"https://orcid.org/0000-0001-9694-7319","observed_orcids":["https://orcid.org/0000-0001-9694-7319"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Deborah A. Robins","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057801880","display_name":"Jahangir Alam","orcid":"https://orcid.org/0000-0002-7935-6346","observed_orcids":["https://orcid.org/0000-0002-7935-6346"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jahangir Alam","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112502760","display_name":"Alan Y. Chiang","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alan Y Chiang","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110274865","display_name":"Leijun Hu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Leijun Hu","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071267554","display_name":"John Henry Krege","orcid":"https://orcid.org/0000-0003-3914-0951","observed_orcids":["https://orcid.org/0000-0003-3914-0951"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John H Krege","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062013397","display_name":"Hideaki Sowa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210108315","display_name":"Eli Lilly (Japan)","ror":"https://ror.org/01sv7f575","country_code":"JP","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210108315"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Hideaki Sowa","raw_affiliation_strings":["Lilly Research Laboratories\u2013JapanKobeHyogoJapan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Lilly Research Laboratories\u2013JapanKobeHyogoJapan","institution_ids":["https://openalex.org/I4210108315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075226333","display_name":"Bruce Mitlak","orcid":"https://orcid.org/0000-0001-7050-0703","observed_orcids":["https://orcid.org/0000-0001-7050-0703"]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Bruce H. Mitlak","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5103509276","display_name":"Stephen L. Myers","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I168537998","display_name":"Eli Lilly (United States)","ror":"https://ror.org/01qat3289","country_code":"US","type":"company","lineage":["https://openalex.org/I168537998"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen L. Myers","raw_affiliation_strings":["Eli Lilly and CompanyIndianapolisINUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and CompanyIndianapolisINUSA","institution_ids":["https://openalex.org/I168537998"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5052478195"],"corresponding_institution_ids":["https://openalex.org/I114493937"],"apc_list":{"value":3780,"currency":"USD","value_usd":3780},"apc_paid":{"value":3780,"currency":"USD","value_usd":3780},"fwci":45.1645,"has_fulltext":true,"cited_by_count":293,"citation_normalized_percentile":{"value":0.99968794,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"30","issue":"2","first_page":"216","last_page":"224"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10071","display_name":"Bone health and osteoporosis research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2732","display_name":"Orthopedics and Sports Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11219","display_name":"Bone Metabolism and Diseases","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/sclerostin","display_name":"sclerostin","score":0.9890000224113464},{"id":"https://openalex.org/keywords/sclerostin-antibody","display_name":"sclerostin antibody","score":0.847000002861023},{"id":"https://openalex.org/keywords/postmenopausal-osteoporosis","display_name":"postmenopausal osteoporosis","score":0.8880000114440918},{"id":"https://openalex.org/keywords/osteopenia","display_name":"osteopenia","score":0.9890000224113464},{"id":"https://openalex.org/keywords/bone-mineral-density","display_name":"bone mineral density","score":0.7789999842643738},{"id":"https://openalex.org/keywords/bone-turnover-markers","display_name":"bone turnover markers","score":0.734000027179718},{"id":"https://openalex.org/keywords/bone-formation","display_name":"bone formation","score":0.6190000176429749},{"id":"https://openalex.org/keywords/bone-resorption","display_name":"bone resorption","score":0.9860000014305115},{"id":"https://openalex.org/keywords/anabolic-therapy","display_name":"anabolic therapy","score":0.6539999842643738},{"id":"https://openalex.org/keywords/osteocytes","display_name":"osteocytes","score":0.7319999933242798}],"concepts":[{"id":"https://openalex.org/C2779277721","wikidata":"https://www.wikidata.org/wiki/Q14887295","display_name":"Sclerostin","level":4,"score":0.8804124593734741},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7887026071548462},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.7497243881225586},{"id":"https://openalex.org/C2776886416","wikidata":"https://www.wikidata.org/wiki/Q4941567","display_name":"Bone mineral","level":3,"score":0.7403397560119629},{"id":"https://openalex.org/C2775854910","wikidata":"https://www.wikidata.org/wiki/Q4844892","display_name":"Femoral neck","level":3,"score":0.7103273868560791},{"id":"https://openalex.org/C170033053","wikidata":"https://www.wikidata.org/wiki/Q952019","display_name":"Bone remodeling","level":2,"score":0.6605710983276367},{"id":"https://openalex.org/C673006","wikidata":"https://www.wikidata.org/wiki/Q4941581","display_name":"Bone resorption","level":2,"score":0.5695229768753052},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.5470113158226013},{"id":"https://openalex.org/C2776541429","wikidata":"https://www.wikidata.org/wiki/Q165328","display_name":"Osteoporosis","level":2,"score":0.5260008573532104},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5013163089752197},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.33655354380607605},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.12410473823547363},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.0888502299785614},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C137620995","wikidata":"https://www.wikidata.org/wiki/Q155769","display_name":"Wnt signaling pathway","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005819","descriptor_name":"Genetic Markers","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015519","descriptor_name":"Bone Density","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015663","descriptor_name":"Osteoporosis, Postmenopausal","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D016723","descriptor_name":"Bone Remodeling","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017698","descriptor_name":"Postmenopause","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D019485","descriptor_name":"Bone Morphogenetic Proteins","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true},{"descriptor_ui":"D048868","descriptor_name":"Adaptor Proteins, Signal Transducing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1002/jbmr.2351","doi":"https://doi.org/10.1002/jbmr.2351","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jbmr.2351","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.2351","source":{"id":"https://openalex.org/S128199769","display_name":"Journal of Bone and Mineral Research","issn_l":"0884-0431","issn":["0884-0431","1523-4681"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bone and Mineral Research","raw_type":"journal-article"},{"id":"pmid:25196993","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25196993","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:cdr.creighton.edu:10504/68156","doi":null,"is_oa":false,"landing_page_url":"http://doi.org/10.1002/jbmr.2351","pdf_url":null,"source":{"id":"https://openalex.org/S7407097583","display_name":"Creighton Digital Repository (CDR)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I114493937","host_organization_name":"Creighton University","host_organization_lineage":["https://openalex.org/I114493937"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1002/jbmr.2351","doi":"https://doi.org/10.1002/jbmr.2351","is_oa":true,"landing_page_url":"https://doi.org/10.1002/jbmr.2351","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/jbmr.2351","source":{"id":"https://openalex.org/S128199769","display_name":"Journal of Bone and Mineral Research","issn_l":"0884-0431","issn":["0884-0431","1523-4681"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Bone and Mineral Research","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1495535606.pdf","grobid_xml":"https://content.openalex.org/works/W1495535606.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W137190687","https://openalex.org/W635116892","https://openalex.org/W1257766419","https://openalex.org/W1516916106","https://openalex.org/W1709742880","https://openalex.org/W1963673901","https://openalex.org/W1965542690","https://openalex.org/W1970875728","https://openalex.org/W1971675936","https://openalex.org/W1991404229","https://openalex.org/W1997201680","https://openalex.org/W2008314623","https://openalex.org/W2016146691","https://openalex.org/W2028910660","https://openalex.org/W2030615058","https://openalex.org/W2032956576","https://openalex.org/W2063588175","https://openalex.org/W2068916684","https://openalex.org/W2096627331","https://openalex.org/W2103033375","https://openalex.org/W2104357139","https://openalex.org/W2114649090","https://openalex.org/W2120377396","https://openalex.org/W2133911598","https://openalex.org/W2163341100","https://openalex.org/W2170298287","https://openalex.org/W2170402173","https://openalex.org/W2335178464","https://openalex.org/W2599867508"],"related_works":["https://openalex.org/W2330823234","https://openalex.org/W2138023846","https://openalex.org/W1516916106","https://openalex.org/W2096627331","https://openalex.org/W2724299157","https://openalex.org/W2088174129","https://openalex.org/W2134793345","https://openalex.org/W2153703573","https://openalex.org/W2617104354","https://openalex.org/W2955498242"],"abstract_inverted_index":{"Sclerostin,":[0],"a":[1,22,33,52,198,210,269],"SOST":[2],"protein":[3],"secreted":[4],"by":[5,178,219],"osteocytes,":[6],"negatively":[7],"regulates":[8],"formation":[9,167],"of":[10,21,31,93,101,165,201,215,243,266],"mineralized":[11],"bone":[12,15,45,102,166,182,202],"matrix":[13],"and":[14,88,95,98,135,157,173,222,258],"mass.":[16],"We":[17],"report":[18],"the":[19,112,144,155,160,194,216],"results":[20,262],"randomized,":[23],"double-blind,":[24],"placebo-controlled":[25],"multicenter":[26],"phase":[27],"2":[28,74,220],"clinical":[29],"trial":[30],"blosozumab,":[32],"humanized":[34],"monoclonal":[35],"antibody":[36,248],"targeted":[37,249],"against":[38,250],"sclerostin,":[39],"in":[40,111,126,131,193,206,253,256],"postmenopausal":[41,244],"women":[42,50,108,245],"with":[43,51,86,141,236,246],"low":[44],"mineral":[46],"density":[47],"(BMD).":[48],"Postmenopausal":[49],"lumbar":[53,119],"spine":[54,94,120,257],"T-score":[55,121],"-2.0":[56],"to":[57,62,209],"-3.5,":[58],"inclusive,":[59],"were":[60,104,109,232],"randomized":[61],"subcutaneous":[63],"blosozumab":[64,171,207,226,237,267],"180":[65,71],"mg":[66,72,78],"every":[67,73],"4":[68],"weeks":[69,75],"(Q4W),":[70],"(Q2W),":[76],"270":[77],"Q2W,":[79],"or":[80],"matching":[81],"placebo":[82,189,217],"for":[83,273],"1":[84],"year,":[85],"calcium":[87],"vitamin":[89],"D.":[90],"Serial":[91],"measurements":[92],"hip":[96,137,259],"BMD":[97,138,148],"biochemical":[99,199],"markers":[100,164],"turnover":[103],"performed.":[105],"Overall,":[106],"120":[107],"enrolled":[110],"study":[113,179,191,265],"(mean":[114],"age":[115],"65.8":[116],"years,":[117],"mean":[118],"-2.8).":[122],"Blosozumab":[123],"treatment":[124,208,242],"resulted":[125,252],"statistically":[127],"significant":[128],"dose-related":[129],"increases":[130,149,255],"spine,":[132,156],"femoral":[133],"neck,":[134],"total":[136,161],"as":[139,268],"compared":[140],"placebo.":[142,239],"In":[143,240],"highest":[145],"dose":[146],"group,":[147],"from":[150],"baseline":[151],"reached":[152],"17.7%":[153],"at":[154,159,190],"6.2%":[158],"hip.":[162],"Biochemical":[163],"increased":[168],"rapidly":[169],"during":[170],"treatment,":[172],"trended":[174],"toward":[175],"pretreatment":[176],"levels":[177],"end.":[180],"However,":[181],"specific":[183],"alkaline":[184],"phosphatase":[185],"remained":[186,223],"higher":[187],"than":[188,213,238],"end":[192],"highest-dose":[195],"group.":[196],"CTx,":[197],"marker":[200],"resorption,":[203],"decreased":[204],"early":[205],"concentration":[211],"less":[212],"that":[214],"group":[218],"weeks,":[221],"reduced":[224],"throughout":[225],"treatment.":[227],"Mild":[228],"injection":[229],"site":[230],"reactions":[231],"reported":[233],"more":[234],"frequently":[235],"conclusion,":[241],"an":[247],"sclerostin":[251],"substantial":[254],"BMD.":[260],"These":[261],"support":[263],"further":[264],"potential":[270],"anabolic":[271],"therapy":[272],"osteoporosis.":[274]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":11},{"year":2023,"cited_by_count":16},{"year":2022,"cited_by_count":26},{"year":2021,"cited_by_count":22},{"year":2020,"cited_by_count":26},{"year":2019,"cited_by_count":22},{"year":2018,"cited_by_count":22},{"year":2017,"cited_by_count":36},{"year":2016,"cited_by_count":52},{"year":2015,"cited_by_count":40},{"year":2014,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}